世界の高フェニルアラニン血症（HPA）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hyperphenylalaninemia (HPA) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2993
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、高フェニルアラニン血症（HPA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、サプリメント）、用途別市場規模（家庭用、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・高フェニルアラニン血症（HPA）の市場動向
・企業の競争状況、市場シェア
・高フェニルアラニン血症（HPA）の種類別市場規模（医薬品、サプリメント）
・高フェニルアラニン血症（HPA）の用途別市場規模（家庭用、病院）
・高フェニルアラニン血症（HPA）の北米市場規模2016-2027（アメリカ、カナダ）
・高フェニルアラニン血症（HPA）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・高フェニルアラニン血症（HPA）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・高フェニルアラニン血症（HPA）の中南米市場規模2016-2027（メキシコ、ブラジル）
・高フェニルアラニン血症（HPA）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Biomarin、Vitaflo、Mead Johnson、Nutricia、Abbott、Dr. Schar、Prominmetabolics、Cambrooke、Juvela、Firstplay Dietary）
・結論

Market Analysis and Insights: Global Hyperphenylalaninemia (HPA) Market
The global Hyperphenylalaninemia (HPA) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hyperphenylalaninemia (HPA) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hyperphenylalaninemia (HPA) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hyperphenylalaninemia (HPA) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hyperphenylalaninemia (HPA) market.

Global Hyperphenylalaninemia (HPA) Scope and Market Size
Hyperphenylalaninemia (HPA) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hyperphenylalaninemia (HPA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medications
Supplements

Segment by Application
Household
Hospital

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Dr. Schar
Prominmetabolics
Cambrooke
Juvela

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperphenylalaninemia (HPA) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications
1.2.3 Supplements
1.3 Market by Application
1.3.1 Global Hyperphenylalaninemia (HPA) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Household
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hyperphenylalaninemia (HPA) Market Perspective (2016-2027)
2.2 Hyperphenylalaninemia (HPA) Growth Trends by Regions
2.2.1 Hyperphenylalaninemia (HPA) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hyperphenylalaninemia (HPA) Historic Market Share by Regions (2016-2021)
2.2.3 Hyperphenylalaninemia (HPA) Forecasted Market Size by Regions (2022-2027)
2.3 Hyperphenylalaninemia (HPA) Industry Dynamic
2.3.1 Hyperphenylalaninemia (HPA) Market Trends
2.3.2 Hyperphenylalaninemia (HPA) Market Drivers
2.3.3 Hyperphenylalaninemia (HPA) Market Challenges
2.3.4 Hyperphenylalaninemia (HPA) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hyperphenylalaninemia (HPA) Players by Revenue
3.1.1 Global Top Hyperphenylalaninemia (HPA) Players by Revenue (2016-2021)
3.1.2 Global Hyperphenylalaninemia (HPA) Revenue Market Share by Players (2016-2021)
3.2 Global Hyperphenylalaninemia (HPA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hyperphenylalaninemia (HPA) Revenue
3.4 Global Hyperphenylalaninemia (HPA) Market Concentration Ratio
3.4.1 Global Hyperphenylalaninemia (HPA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperphenylalaninemia (HPA) Revenue in 2020
3.5 Hyperphenylalaninemia (HPA) Key Players Head office and Area Served
3.6 Key Players Hyperphenylalaninemia (HPA) Product Solution and Service
3.7 Date of Enter into Hyperphenylalaninemia (HPA) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hyperphenylalaninemia (HPA) Breakdown Data by Type
4.1 Global Hyperphenylalaninemia (HPA) Historic Market Size by Type (2016-2021)
4.2 Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Type (2022-2027)

5 Hyperphenylalaninemia (HPA) Breakdown Data by Application
5.1 Global Hyperphenylalaninemia (HPA) Historic Market Size by Application (2016-2021)
5.2 Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hyperphenylalaninemia (HPA) Market Size (2016-2027)
6.2 North America Hyperphenylalaninemia (HPA) Market Size by Type
6.2.1 North America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021)
6.2.2 North America Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027)
6.2.3 North America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2027)
6.3 North America Hyperphenylalaninemia (HPA) Market Size by Application
6.3.1 North America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021)
6.3.2 North America Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027)
6.3.3 North America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2027)
6.4 North America Hyperphenylalaninemia (HPA) Market Size by Country
6.4.1 North America Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021)
6.4.2 North America Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hyperphenylalaninemia (HPA) Market Size (2016-2027)
7.2 Europe Hyperphenylalaninemia (HPA) Market Size by Type
7.2.1 Europe Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021)
7.2.2 Europe Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027)
7.2.3 Europe Hyperphenylalaninemia (HPA) Market Size by Type (2016-2027)
7.3 Europe Hyperphenylalaninemia (HPA) Market Size by Application
7.3.1 Europe Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021)
7.3.2 Europe Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027)
7.3.3 Europe Hyperphenylalaninemia (HPA) Market Size by Application (2016-2027)
7.4 Europe Hyperphenylalaninemia (HPA) Market Size by Country
7.4.1 Europe Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021)
7.4.2 Europe Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size (2016-2027)
8.2 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type
8.2.1 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type (2016-2027)
8.3 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application
8.3.1 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application (2016-2027)
8.4 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Region
8.4.1 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hyperphenylalaninemia (HPA) Market Size (2016-2027)
9.2 Latin America Hyperphenylalaninemia (HPA) Market Size by Type
9.2.1 Latin America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021)
9.2.2 Latin America Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027)
9.2.3 Latin America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2027)
9.3 Latin America Hyperphenylalaninemia (HPA) Market Size by Application
9.3.1 Latin America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021)
9.3.2 Latin America Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027)
9.3.3 Latin America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2027)
9.4 Latin America Hyperphenylalaninemia (HPA) Market Size by Country
9.4.1 Latin America Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021)
9.4.2 Latin America Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size (2016-2027)
10.2 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type
10.2.1 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type (2016-2027)
10.3 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application
10.3.1 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application (2016-2027)
10.4 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Country
10.4.1 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biomarin
11.1.1 Biomarin Company Details
11.1.2 Biomarin Business Overview
11.1.3 Biomarin Hyperphenylalaninemia (HPA) Introduction
11.1.4 Biomarin Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.1.5 Biomarin Recent Development
11.2 Vitaflo
11.2.1 Vitaflo Company Details
11.2.2 Vitaflo Business Overview
11.2.3 Vitaflo Hyperphenylalaninemia (HPA) Introduction
11.2.4 Vitaflo Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.2.5 Vitaflo Recent Development
11.3 Mead Johnson
11.3.1 Mead Johnson Company Details
11.3.2 Mead Johnson Business Overview
11.3.3 Mead Johnson Hyperphenylalaninemia (HPA) Introduction
11.3.4 Mead Johnson Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.3.5 Mead Johnson Recent Development
11.4 Nutricia
11.4.1 Nutricia Company Details
11.4.2 Nutricia Business Overview
11.4.3 Nutricia Hyperphenylalaninemia (HPA) Introduction
11.4.4 Nutricia Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.4.5 Nutricia Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Hyperphenylalaninemia (HPA) Introduction
11.5.4 Abbott Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Dr. Schar
11.6.1 Dr. Schar Company Details
11.6.2 Dr. Schar Business Overview
11.6.3 Dr. Schar Hyperphenylalaninemia (HPA) Introduction
11.6.4 Dr. Schar Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.6.5 Dr. Schar Recent Development
11.7 Prominmetabolics
11.7.1 Prominmetabolics Company Details
11.7.2 Prominmetabolics Business Overview
11.7.3 Prominmetabolics Hyperphenylalaninemia (HPA) Introduction
11.7.4 Prominmetabolics Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.7.5 Prominmetabolics Recent Development
11.8 Cambrooke
11.8.1 Cambrooke Company Details
11.8.2 Cambrooke Business Overview
11.8.3 Cambrooke Hyperphenylalaninemia (HPA) Introduction
11.8.4 Cambrooke Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.8.5 Cambrooke Recent Development
11.9 Juvela
11.9.1 Juvela Company Details
11.9.2 Juvela Business Overview
11.9.3 Juvela Hyperphenylalaninemia (HPA) Introduction
11.9.4 Juvela Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.9.5 Juvela Recent Development
11.10 Firstplay Dietary
11.10.1 Firstplay Dietary Company Details
11.10.2 Firstplay Dietary Business Overview
11.10.3 Firstplay Dietary Hyperphenylalaninemia (HPA) Introduction
11.10.4 Firstplay Dietary Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021)
11.10.5 Firstplay Dietary Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hyperphenylalaninemia (HPA) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications
Table 3. Key Players of Supplements
Table 4. Global Hyperphenylalaninemia (HPA) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hyperphenylalaninemia (HPA) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hyperphenylalaninemia (HPA) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2016-2021)
Table 8. Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2022-2027)
Table 10. Hyperphenylalaninemia (HPA) Market Trends
Table 11. Hyperphenylalaninemia (HPA) Market Drivers
Table 12. Hyperphenylalaninemia (HPA) Market Challenges
Table 13. Hyperphenylalaninemia (HPA) Market Restraints
Table 14. Global Hyperphenylalaninemia (HPA) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hyperphenylalaninemia (HPA) Market Share by Players (2016-2021)
Table 16. Global Top Hyperphenylalaninemia (HPA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperphenylalaninemia (HPA) as of 2020)
Table 17. Ranking of Global Top Hyperphenylalaninemia (HPA) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hyperphenylalaninemia (HPA) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hyperphenylalaninemia (HPA) Product Solution and Service
Table 21. Date of Enter into Hyperphenylalaninemia (HPA) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Type (2016-2021)
Table 25. Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hyperphenylalaninemia (HPA) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Application (2016-2021)
Table 29. Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biomarin Company Details
Table 62. Biomarin Business Overview
Table 63. Biomarin Hyperphenylalaninemia (HPA) Product
Table 64. Biomarin Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 65. Biomarin Recent Development
Table 66. Vitaflo Company Details
Table 67. Vitaflo Business Overview
Table 68. Vitaflo Hyperphenylalaninemia (HPA) Product
Table 69. Vitaflo Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 70. Vitaflo Recent Development
Table 71. Mead Johnson Company Details
Table 72. Mead Johnson Business Overview
Table 73. Mead Johnson Hyperphenylalaninemia (HPA) Product
Table 74. Mead Johnson Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 75. Mead Johnson Recent Development
Table 76. Nutricia Company Details
Table 77. Nutricia Business Overview
Table 78. Nutricia Hyperphenylalaninemia (HPA) Product
Table 79. Nutricia Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 80. Nutricia Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Hyperphenylalaninemia (HPA) Product
Table 84. Abbott Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Dr. Schar Company Details
Table 87. Dr. Schar Business Overview
Table 88. Dr. Schar Hyperphenylalaninemia (HPA) Product
Table 89. Dr. Schar Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 90. Dr. Schar Recent Development
Table 91. Prominmetabolics Company Details
Table 92. Prominmetabolics Business Overview
Table 93. Prominmetabolics Hyperphenylalaninemia (HPA) Product
Table 94. Prominmetabolics Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 95. Prominmetabolics Recent Development
Table 96. Cambrooke Company Details
Table 97. Cambrooke Business Overview
Table 98. Cambrooke Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 99. Cambrooke Recent Development
Table 100. Juvela Company Details
Table 101. Juvela Business Overview
Table 102. Juvela Hyperphenylalaninemia (HPA) Product
Table 103. Juvela Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 104. Juvela Recent Development
Table 105. Firstplay Dietary Company Details
Table 106. Firstplay Dietary Business Overview
Table 107. Firstplay Dietary Hyperphenylalaninemia (HPA) Product
Table 108. Firstplay Dietary Revenue in Hyperphenylalaninemia (HPA) Business (2016-2021) & (US$ Million)
Table 109. Firstplay Dietary Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hyperphenylalaninemia (HPA) Market Share by Type: 2020 VS 2027
Figure 2. Medications Features
Figure 3. Supplements Features
Figure 4. Global Hyperphenylalaninemia (HPA) Market Share by Application: 2020 VS 2027
Figure 5. Household Case Studies
Figure 6. Hospital Case Studies
Figure 7. Hyperphenylalaninemia (HPA) Report Years Considered
Figure 8. Global Hyperphenylalaninemia (HPA) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Hyperphenylalaninemia (HPA) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hyperphenylalaninemia (HPA) Market Share by Regions: 2020 VS 2027
Figure 11. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2022-2027)
Figure 12. Global Hyperphenylalaninemia (HPA) Market Share by Players in 2020
Figure 13. Global Top Hyperphenylalaninemia (HPA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperphenylalaninemia (HPA) as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Hyperphenylalaninemia (HPA) Revenue in 2020
Figure 15. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Type (2016-2021)
Figure 16. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Type (2022-2027)
Figure 17. North America Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Hyperphenylalaninemia (HPA) Market Share by Type (2016-2027)
Figure 19. North America Hyperphenylalaninemia (HPA) Market Share by Application (2016-2027)
Figure 20. North America Hyperphenylalaninemia (HPA) Market Share by Country (2016-2027)
Figure 21. United States Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hyperphenylalaninemia (HPA) Market Share by Type (2016-2027)
Figure 25. Europe Hyperphenylalaninemia (HPA) Market Share by Application (2016-2027)
Figure 26. Europe Hyperphenylalaninemia (HPA) Market Share by Country (2016-2027)
Figure 27. Germany Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hyperphenylalaninemia (HPA) Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Hyperphenylalaninemia (HPA) Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Hyperphenylalaninemia (HPA) Market Share by Region (2016-2027)
Figure 37. China Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hyperphenylalaninemia (HPA) Market Share by Type (2016-2027)
Figure 45. Latin America Hyperphenylalaninemia (HPA) Market Share by Application (2016-2027)
Figure 46. Latin America Hyperphenylalaninemia (HPA) Market Share by Country (2016-2027)
Figure 47. Mexico Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hyperphenylalaninemia (HPA) Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Hyperphenylalaninemia (HPA) Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Hyperphenylalaninemia (HPA) Market Share by Country (2016-2027)
Figure 53. Turkey Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Hyperphenylalaninemia (HPA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Biomarin Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 57. Vitaflo Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 58. Mead Johnson Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 59. Nutricia Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 61. Dr. Schar Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 62. Prominmetabolics Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 63. Cambrooke Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 64. Juvela Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 65. Firstplay Dietary Revenue Growth Rate in Hyperphenylalaninemia (HPA) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Global InfiniBand Market Size, Status and Forecast 2021-2027
QYR2104Z3157 2021年4月 98Pages
QYResearch社発行の本調査資料では、インフィニバンド（InfiniBand）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シングルデータレート、ダブルデータレート、クワッドデータレート、14データレート、拡張データレート）、用途別市場...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の3D動脈スピンラベリング（3D ASL）市場規模・現状・予測（2021年-2027年）

Global 3D Arterial Spin Labeling (3D ASL) Market Size, Status and Forecast 2021-2027
QYR2104Z6125 2021年4月 96Pages
QYResearch社発行の本調査資料では、3D動脈スピンラベリング（3D ASL）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キャッスル（CASL）、PASL）、用途別市場規模（腫瘍、脳血管障害、神経変性疾患、パーキンソン病）、主要地域別...

世界の癌胎児性抗原（CEA）市場規模・現状・予測（2021年-2027年）

Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2021-2027
QYR2104Z1106 2021年4月 90Pages
QYResearch社発行の本調査資料では、癌胎児性抗原（CEA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）、用途別市場規模（大腸がん、膵臓がん、卵巣がん、乳がん、甲...

世界のチャネルインアボックス（CiaB）市場規模・現状・予測（2021年-2027年）

Global Channel-in-a-Box Market Size, Status and Forecast 2021-2027
QYR2104Z1255 2021年4月 94Pages
QYResearch社発行の本調査資料では、チャネルインアボックス（CiaB）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソフトウェア、ハードウェア）、用途別市場規模（住宅用、商業用、公共・政府インフラストラクチャ）、主要地域別市場規模（...

世界のエキシマレーザアニール装置（ELA）市場規模・現状・予測（2021年-2027年）

Global Excimer Laser Annealing (ELA) Market Size, Status and Forecast 2021-2027
QYR2104Z2268 2021年4月 94Pages
QYResearch社発行の本調査資料では、エキシマレーザアニール装置（ELA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（XeCl（308nm）ELA、KrF（248nm）ELA）、用途別市場規模（工業、実験室、その他）、主要地域別市場規...

世界のシリコン貫通電極（TSV）市場規模・現状・予測（2021年-2027年）

Global Through Silicon Via (TSV) Market Size, Status and Forecast 2021-2027
QYR2104Z5647 2021年4月 90Pages
QYResearch社発行の本調査資料では、シリコン貫通電極（TSV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（2.5D TSV、3D TSV）、用途別市場規模（移動・家電、通信機器、自動車・輸送用電子機器、その他）、主要地域別市場規模（...

世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年）

Global High-Throughput Sequencing (HTS) Market Size, Status and Forecast 2021-2027
QYR2104Z2845 2021年4月 93Pages
QYResearch社発行の本調査資料では、ハイスループットシーケンシング（HTS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成シーケンシング、連結シーケンシング）、用途別市場規模（腫瘍、遺伝性疾患検出、生命科学）、主要地域別市場規模（...

世界の関節部分置換術（PKR）市場規模・現状・予測（2021年-2027年）

Global Partial Knee Replacement (PKR) Market Size, Status and Forecast 2021-2027
QYR2104Z4448 2021年4月 92Pages
QYResearch社発行の本調査資料では、関節部分置換術（PKR）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（移植、非移植）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の急性反復発作（ARS）市場規模・現状・予測（2021年-2027年）

Global Acute Repetitive Seizures Market Size, Status and Forecast 2021-2027
QYR2104Z0078 2021年4月 96Pages
QYResearch社発行の本調査資料では、急性反復発作（ARS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（USL-261、NRL-1、AZ-002、ダイアスタットレクタルジェル、その他）、用途別市場規模（病院、クリニック）、主要地域別市...

世界の精神治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Psychiatric Medications Market The global Psychiatric Medications market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界の副鼻腔炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sinusitis Medications Market The global Sinusitis Medications market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界の臓器移植拒絶反応抑制剤市場規模・現状・予測（2021年-2027年） Organ transplant anti-rejection medications are drugs that prevent the body from attacking the transplanted organ cells after organ transplantation, and help organs survive in the recipient after organ transplantation. Market Analysis and Insights: Global Organ Transplant Anti-rejection Medications …
世界の臓器移植拒絶反応抑制剤市場規模・現状・予測（2021年-2027年） Organ transplant anti-rejection medications are drugs that prevent the body from attacking the transplanted organ cells after organ transplantation, and help organs survive in the recipient after organ transplantation. Market Analysis and Insights: Global Organ Transplant Anti-rejection Medications …
世界のADHD治療薬市場規模・現状・予測（2021年-2027年） ADHD medications can help reduce symptoms of hyperactivity, inattentiveness, and impulsivity in children and adults with attention deficit hyperactivity disorder (ADHD), formerly known as ADD. Market Analysis and Insights: Global ADHD Medications Market The global ADHD Medications market size is pr…